PDL: Cook Williams Communications, Inc

The following excerpt is from the company's SEC filing.

775-832-8500

360-668-3701

Peter.Garcia@pdl.com

jennifer@cwcomm.org

PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017

INCLINE VILLAGE, NV, April 6, 2017 – PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on Friday, June 9, 2017, at 10:00 a.m. Pacific Time for all stockholders of record on April 17, 2017. The meeting will take place at the Hyatt Regency Hotel in Incline Village, Nevada.

About PDL BioPharma

PDL seeks to provide a significant return for its shareholder s by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries.  In late 2012, PDL began providing alternative sources of capital through royalty monetizations and debt facilities and in 2016, began making equity investments in commercial stage companies, the first being Noden Pharma DAC.  PDL has committed over $1.4 billion and funded approximately $1.1 billion in these investments to date.  PDL is headquartered in Incline Village, Nevada. 

For more information, please visit www.pdl.com.

PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!

Other recent filings from the company include the following:

Departure of Directors or Certain - June 14, 2018
PDL BioPharma director just picked up 54,348 shares - June 12, 2018
PDL BioPharma director just picked up 54,348 shares - June 12, 2018
PDL BioPharma's CEO was just granted 1,922,100 options - June 12, 2018
PDL BioPharma director just picked up 54,348 shares - June 12, 2018

Auto Refresh

Feedback